Modulation of protein kinase C and cAMP-dependent protein kinase by delta-opioid.
Modulation of protein kinase C (PKC) and cAMP-dependent protein kinase (PKA) activities by delta-opioid receptor specific agonist [D-Pen2, D-Pen5]-enkephalin (DPDPE) was investigated in neuroblastoma x glioma hybrid NG 108-15 cells. DPDPE activated PKC in a dose-dependent manner, with the maximal response at 5 min. The DPDPE-stimulated PKC activation could be blocked by naltrindole. The activation of PKC by DPDPE was dependent on Ca2+ and was inhibited by chelerythrine chloride (10 microM), but not by H89 (1 microM). Pretreatment of NG 108-15 cells with pertussis toxin (100 ng/ml for 24 h) completely abolished DPDPE-stimulated PKC activation. In contrast to the result from the acute treatment with DPDPE, which had no significant effect on PKA activity, chronic treatment of DPDPE (1 microM for 24 h) increased PKA activity, but reduced the basal activity of PKC. These results demonstrated that DPDPE differentially modulated PKC and PKA activities via a receptor-mediated, PTX sensitive pathway.
Lou
L G
LG
Shanghai Institute of Cell Biology, Chinese Academy of Sciences, People's Republic of China.
Pei
G
G
D002118:Calcium / Q000494:pharmacology; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism*; D020881:Enkephalin, D-Penicillamine (2,5)-; D004745:Enkephalins / Q000494:pharmacology*; D004789:Enzyme Activation; D005910:Glioma; D006822:Hybrid Cells; D007700:Kinetics; D009447:Neuroblastoma; D037342:Pertussis Toxin; D011493:Protein Kinase C / Q000378:metabolism*; D017465:Receptors, Opioid, delta / Q000819:agonists* / Q000502:physiology*; D014407:Tumor Cells, Cultured; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D004745:Enkephalins; D017465:Receptors, Opioid, delta; D010566:Virulence Factors, Bordetella; D020881:Enkephalin, D-Penicillamine (2,5)-; D037342:Pertussis Toxin; D017868:Cyclic AMP-Dependent Protein Kinases; D011493:Protein Kinase C; D002118:Calcium